Modern HIV Vaccine. AIDS mRNA vaccine trials begin

NEW YORK.

The modern pharmaceutical launched his draft from mRNA vaccine against VIH / page, opening the esperanza to achieve a long-awaited medical milestone.

The draft is a collaboration between Modern, the International AIDS Vaccine Initiative (IAVI) and the Bill and Melinda Gates Foundation (BMGF), reports the Official site clinicaltrials.gov.

Phase 1 clinical trials include 56 healthy HIV-negative adults to test mRNA-1644 vaccine safety and basic immune response.

This vaccine candidate is based on the same platform of MRNA that the immunizer against covid-19 developed by Moderna.

MRNA-1644 will be the first HIV mRNA vaccine to be tested in humans.

Moderna will also test another version of the candidate called mRNA-1644v2-Core.

Both have been tested for safety in non-human subjects.

The director of the US company, Stéphane Bancel, anticipated last January that Moderna would launch in search of a cutting-edge vaccine against HIV.

In the announcement, he revealed two other vaccine projects focused on seasonal flu and Nipah virus.

jrr

.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Never miss any important news. Subscribe to our newsletter.